Annals of Nutrition and Metabolism

Original Paper

Higher Levels of Magnesium and Lower Levels of Calcium in Whole Blood Are Positively Correlated with the Metabolic Syndrome in a Chinese Population: A Case-Control Study

Yuan Z.a · Liu C.e · Tian Y.c · Zhang X.d · Ye H.b · Jin L.b · Ruan L.e · Sun Z.e · Zhu Y.a

Author affiliations

aDepartment of Epidemiology and Biostatistics, and bCenter for Experimental Teaching, Zhejiang University School of Public Health, cDepartment of Pathology, Zhejiang University School of Medicine, and dDepartment of Nutrition and Food Safety, Hangzhou Center for Disease Control and Prevention, Hangzhou, and eDepartment of Endocrinology and Institute of Cardiovascular Diseases, Zhejiang Putuo Hospital, Zhoushan, China

Keywords: MagnesiumCalciumCa to Mg ratioMetabolic syndrome

Related Articles for ""
Ann Nutr Metab 2016;69:125-134
https://doi.org/10.1159/000450761

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 22, 2016
Accepted: September 10, 2016
Published online: October 18, 2016
Issue release date: November 2016

Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 5

ISSN: 0250-6807 (Print)
eISSN: 1421-9697 (Online)

For additional information: https://www.karger.com/ANM

Abstract

Magnesium (Mg) and calcium (Ca) are essential for numerous kinds of metabolisms in human body. To investigate the associations between Mg and Ca and the ratio of Ca to Mg (Ca/Mg) in whole blood with metabolic syndrome (MetS) in a Chinese population, a matched case-control study including 204 MetS patients and 204 healthy controls (aged 48-89) was carried out in 2011. MetS were diagnosed according to the criteria of Chinese Diabetes Society. Controls had no abnormal metabolic components and were matched with cases by age, gender and region. Blood samples were collected in the morning after an overnight fast. Whole blood Mg and Ca were determined by flame atomic absorption spectrometry. Subjects who were male constituted 44.1% of the part of this study. The average age was 64.0 ± 7.18, and the average body mass index was 24.3 ± 3.75. The MetS group showed significantly higher Mg and lower Ca and Ca/Mg as compared with the control group. Comparing with the bottom tertile (T1) of Mg, increased ORs for MetS were found in median tertile (T2) and top tertile (T3) of Mg. For Ca, T2 and T3 were negatively associated with MetS. Inverse relationship was also found between Ca/Mg ratio and MetS. Our findings suggested that increased Mg and decreased Ca and Ca/Mg in whole blood were correlated with MetS in Chinese adults.

© 2016 S. Karger AG, Basel

References

  1. DeFronzo RA: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 1997;50:191-197.
  2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
  3. Cameron AJ, Shaw JE, Zimmet PZ: The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351-375.
  4. Ford ES, Li C, Zhao G: Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes 2010;2:180-193.
  5. Hollman G, Kristenson M: The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population - mainly a function of overweight? Eur J Cardiovasc Nurs 2008;7:21-26.
  6. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 2015;313:1973-1974.
  7. Xi B, He D, Hu Y, Zhou D: Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009. Prev Med 2013;57:867-871.
  8. Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-823.
  9. Paolisso G, Barbagallo M: Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 1997;10:346-355.
  10. Sun G, Vasdev S, Martin GR, Gadag V, Zhang H: Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the newfoundland population. Diabetes 2005;54:3336-3339.
  11. Volpe SL: Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit Rev Food Sci Nutr 2008;48:293-300.
  12. Wilcox G: Insulin and insulin resistance. Clin Biochem Rev 2005;26:19-39.
  13. Barbagallo M, Dominguez LJ: Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007;458:40-47.
  14. Randell EW, Mathews M, Gadag V, Zhang H, Sun G: Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis 2008;196:413-419.
  15. Ford ES, Li C, McGuire LC, Mokdad AH, Liu S: Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S. adults. Obesity (Silver Spring) 2007;15:1139-1146.
  16. Guerrero-Romero F, Rodríguez-Morán M: Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209-213.
  17. Huang JH, Lu YF, Cheng FC, Lee JN, Tsai LC: Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study. Nutr J 2012;11:41.
  18. Yu Y, Cai Z, Zheng J, Chen J, Zhang X, Huang XF, et al: Serum levels of polyunsaturated fatty acids are low in Chinese men with metabolic syndrome, whereas serum levels of saturated fatty acids, zinc, and magnesium are high. Nutr Res 2012;32:71-77.
  19. Peacock M: Calcium metabolism in health and disease. Clin J Am Soc Nephrol 2010;5(suppl 1):S23-S30.
  20. Mears D: Regulation of insulin secretion in islets of Langerhans by Ca(2+)channels. J Membr Biol 2004;200:57-66.
  21. Ahlström T, Hagström E, Larsson A, Rudberg C, Lind L, Hellman P: Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol (Oxf) 2009;71:673-678.
  22. Yamaguchi T, Kanazawa I, Takaoka S, Sugimoto T: Serum calcium is positively correlated with fasting plasma glucose and insulin resistance, independent of parathyroid hormone, in male patients with type 2 diabetes mellitus. Metabolism 2011;60:1334-1339.
  23. Shin SK, Kim MK, Lee YH, Shin DH, Shin MH, Chun BY, et al: The cross-sectional relationship between dietary calcium intake and metabolic syndrome among men and women aged 40 or older in rural areas of Korea. Nutr Res Pract 2015;9:328-335.
  24. Resnick LM: Cellular ions in hypertension, insulin resistance, obesity, and diabetes: a unifying theme. J Am Soc Nephrol 1992;3(4 suppl):S78-S85.
  25. Resnick LM: Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med 1992;93:11S-20S.
  26. Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH: Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension 1991;17(6 pt 2):​951-957.
  27. Park SH, Kim SK, Bae YJ: Relationship between serum calcium and magnesium concentrations and metabolic syndrome diagnostic components in middle-aged Korean men. Biol Trace Elem Res 2012;146:35-41.
  28. Choi WS, Kim SH, Chung JH: Relationships of hair mineral concentrations with insulin resistance in metabolic syndrome. Biol Trace Elem Res 2014;158:323-329.
  29. Metabolic syndrome study cooperation group of Chinese diabetes society: Suggestions about metabolic syndrome of Chinese diabetes society. Chin J Diabetes 2004;12:156-161.
  30. Currie LA: Nomenclature in evaluation of analytical methods including detection and quantification capabilities. Anal Chim Acta 1999;391:105-126.
  31. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, et al: Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003;24:39-52.
  32. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A: Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294:1-26.
  33. Dimai HP, Wirnsberger G, Lau KH: Measurements of circulating ionized magnesium level: fresh whole blood samples versus serum samples. Clin Biochem 2000;33:329-332.
  34. Paolisso G: Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 1997;10:346-355.
  35. Paolisso G, Scheen A, D'Onofrio F, Lefèbvre P: Magnesium and glucose homeostasis. Diabetologia 1990;33:511-514.
  36. Iseri LT, French JH: Magnesium: nature's physiologic calcium blocker. Am Heart J 1984;108:188-193.
  37. White RE, Hartzell HC: Magnesium ions in cardiac function. Regulator of ion channels and second messengers. Biochem Pharmacol 1989;38:859-867.
  38. Sales CH, Santos AR, Cintra DE, Colli C: Magnesium-deficient high-fat diet: effects on adiposity, lipid profile and insulin sensitivity in growing rats. Clin Nutr 2014;33:879-888.
  39. Bo S, Pisu E: Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol 2008;19:50-56.
  40. Lima MDe L, Pousada J, Barbosa C, Cruz T: Deficiência de magnésio e resistência à insulina em pacientes com diabetes mellitus tipo 2. Arq Bras Endocrinol Metabol 2005;49:959-963.
  41. Guerrero-Romero F, Rodríguez-Morán M: Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 2006;22:471-476.
  42. Ghasemi A, Zahediasl S, Syedmoradi L, Azizi F: Low serum magnesium levels in elderly subjects with metabolic syndrome. Biol Trace Elem Res 2010;136:18-25.
  43. Rotter I, Kosik-Bogacka D, Dołęgowska B, Safranow K, Lubkowska A, Laszczyńska M: Relationship between the concentrations of heavy metals and bioelements in aging men with metabolic syndrome. Int J Environ Res Public Health 2015;12:3944-3961.
  44. La SA, Lee JY, Kim do H, Song EL, et al: Low magnesium levels in adults with metabolic syndrome: a meta-analysis. Biol Trace Elem Res 2016;170:33-42.
  45. Chung JH, Yum KS: Correlation of hair mineral concentrations with insulin resistance in Korean males. Biol Trace Elem Res 2012;150:26-30.
  46. Mahfouz MM, Kummerow FA: Effect of magnesium deficiency on delta 6 desaturase activity and fatty acid composition of rat liver microsomes. Lipids 1989;24:727-732.
  47. Touyz RM: Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 2003;24:107-136.
  48. Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Weltman AL, Holmes VF, et al: Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005;28:1175-1181.
  49. Liu WM, Zhu ZG, Leng HX: [Analysis of the contents of K, Na, Ca, Mg, Zn, Cu, Fe and Mn in serum of middle and old-aged hypertension patients]. Guang Pu Xue Yu Guang Pu Fen Xi 2004;24:360-362.
  50. Kesteloot H, Joossens JV: The relationship between dietary intake and urinary excretion of sodium, potassium, calcium and magnesium: Belgian Interuniversity Research on Nutrition and Health. J Hum Hypertens 1990;4:527-533.
  51. Mirmiran P, Shab-Bidar S, Hosseini-Esfahani F, Asghari G, Hosseinpour-Niazi S, Azizi F: Magnesium intake and prevalence of metabolic syndrome in adults: Tehran Lipid and Glucose Study. Public Health Nutr 2012;15:693-701.
  52. Swaminathan R: Magnesium metabolism and its disorders. Clin Biochem Rev 2003;24:47-66.
  53. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy: Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-795.
  54. Secher M, Ritz P, Vellas B: Nutrition and Aging. Present Knowledge in Nutrition, 2012, pp 654-668.
  55. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA: Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 1988;82:1848-1852.
  56. Begum N, Sussman KE, Draznin B: High levels of cytosolic free calcium inhibit dephosphorylation of insulin receptor and glycogen synthase. Cell Calcium 1991;12:423-430.
  57. McCarron DA: Calcium metabolism in hypertension. Keio J Med 1995;44:105-114.
  58. Levy J, Gavin JR 3rd, Sowers JR: Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 1994;96:260-273.
  59. Zemel MB: Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 2001;20(5 suppl):428S-435S; discussion 440S-442S.
  60. Moore-Schiltz L, Albert JM, et al: Dietary intake of calcium and magnesium and the metabolic syndrome in the National Health and Nutrition Examination (NHANES) 2001-2010 data. Br J Nutr 2015;114:924-935.
  61. Richart T, Thijs L, Nawrot T, et al: The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D(3) ratio in a general population. Am J Hypertens 2011;24:102-109.
  62. Liu S, Song Y, Ford ES, Manson JE, et al: Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005;28:2926-2932.
  63. Huang L, Xue J, He Y, Wang J, Sun C, Feng R, et al: Dietary calcium but not elemental calcium from supplements is associated with body composition and obesity in Chinese women. PLoS One 2011;6:e27703.
  64. Wennersberg MH, et al: Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study. Am J Clin Nutr 2009;90:960-968.
  65. Cho G, Park HT, Shin JH, Hur JY, Kim YT, et al: Calcium intake is inversely associated with metabolic syndrome in postmenopausal women: Korea National Health and Nutrition Survey, 2001 and 2005. Menopause 2009;16:992-997.
  66. Bussière FI, Gueux E, Rock E, Mazur A, Rayssiguier Y: Protective effect of calcium deficiency on the inflammatory response in magnesium-deficient rats. Eur J Nutr 2002;41:197-202.
  67. Zemel MB: Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem 1998;188:129-136.
  68. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC: Regulation of adiposity by dietary calcium. FASEB J 2000;14:1132-1138.
  69. Farhangi MA, Ostadrahimi A, Mahboob S: Serum calcium, magnesium, phosphorous and lipid profile in healthy Iranian premenopausal women. Biochem Med (Zagreb) 2011;21:312-320.
  70. Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S: Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 1988;297:960-963.
  71. Jorde R, Figenschau Y, et al: High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr 2010;64:1457-1464.
  72. Jorde R, Sneve M, et al: No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010;267:462-472.
  73. Baldi S, Natali A, Buzzigoli G, Galvan AQ, et al: In vivo effect of insulin on intracellular calcium concentrations: relation to insulin resistance. Metabolism 1996;45:1402-1407.
  74. Brown EM, MacLeod RJ: Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001;81:239-297.
  75. Norman DA, Fordtran JS, et al: Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest 1981;67:1599-1603.
  76. Resnick LM: Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of ‘syndrome X'. Am J Hypertens 1993;6:123S-134S.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 22, 2016
Accepted: September 10, 2016
Published online: October 18, 2016
Issue release date: November 2016

Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 5

ISSN: 0250-6807 (Print)
eISSN: 1421-9697 (Online)

For additional information: https://www.karger.com/ANM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2016, Vol.69, No. 2

November 2016

Article

TAP Icon This Article is Part of
Recommend This
Additional Information

Z.Y. and C.L. contributed equally to this work.
TOP